Genentech, Inc. et al v. Shilpa Medicare Limited
| Genentech, Inc. and InterMune, Inc. |
| Shilpa Medicare Limited |
| 1:2020cv00624 |
| May 8, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 15, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 NOTICE OF SERVICE of (1) Plaintiffs' Initial Claim Charts Shilpa 267 and 801 MG Tablets, (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures, and (3) Plaintiffs' Paragraph 4(a) Disclosures filed by Genentech, Inc., InterMune, Inc..(Clark, Cameron) |
Filing 12
SO ORDERED Granting (122 in 19-cv-78-RGA; 11 in 20-cv-624-RGA) Stipulation and Order for Consolidation. Signed by Judge Richard G. Andrews on 6/4/2020. Associated Cases: 1:19-cv-00078-RGA, 1:20-cv-00624-RGA(nms)
|
| Filing 11 Proposed Stipulation and Order for Consolidation, by Genentech, Inc., InterMune, Inc.. (Clark, Cameron) Modified on 6/4/2020 (nms). |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shilpa Medicare Limited. (Belgam, Neal) |
| Filing 9 ANSWER to #1 Complaint, and Additional Defenses, by Shilpa Medicare Limited.(Ormerod, Eve) Modified on 5/18/2020 (nms). |
| Filing 8 WAIVER OF SERVICE returned executed by Genentech, Inc., InterMune, Inc.: For Shilpa Medicare Limited waiver sent on 5/11/2020, answer due 7/10/2020. (Jacobs, Karen) |
| Filing 7 REQUEST FOR WAIVER of Service sent to Shilpa Medicare Limited on May 11, 2020 by Genentech, Inc., InterMune, Inc.. Waiver of Service due by 8/10/2020. (Jacobs, Karen) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Genetech, Inc. for InterMune, Inc.; Corporate Parent Roche Holdings, Inc. for Genentech, Inc. which is indirectly wholly owned by Roche Holding Ltd. and that Novartis Ltd. owns more than 10% of the stock in Roche Holding Ltd. filed by Genentech, Inc., InterMune, Inc.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): see attached list. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attached list. Date of Expiration of Patent: see attached list. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Shilpa Medicare Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2923944.) - filed by Genentech, Inc., InterMune, Inc.. (Attachments: #1 Exhibit 1-10, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
